HomeCompareSHANF vs PFE

SHANF vs PFE: Dividend Comparison 2026

SHANF yields 153.14% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHANF wins by $24.4K in total portfolio value
10 years
SHANF
SHANF
● Live price
153.14%
Share price
$1.31
Annual div
$2.00
5Y div CAGR
-44.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$74.0K
Annual income
$148.25
Full SHANF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — SHANF vs PFE

📍 SHANF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHANFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHANF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHANF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHANF
Annual income on $10K today (after 15% tax)
$13,016.85/yr
After 10yr DRIP, annual income (after tax)
$126.01/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,193.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHANF + PFE for your $10,000?

SHANF: 50%PFE: 50%
100% PFE50/50100% SHANF
Portfolio after 10yr
$61.8K
Annual income
$13,203.48/yr
Blended yield
21.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

SHANF
No analyst data
Altman Z
3.5
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHANF buys
0
PFE buys
0
No recent congressional trades found for SHANF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHANFPFE
Forward yield153.14%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-44.9%13.2%
Portfolio after 10y$74.0K$49.6K
Annual income after 10y$148.25$26,258.71
Total dividends collected$33.4K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SHANF vs PFE ($10,000, DRIP)

YearSHANF PortfolioSHANF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$19,138$8,437.98$9,153$693.39+$10.0KSHANF
2$28,793$8,315.77$8,593$849.25+$20.2KSHANF
3$37,252$6,442.69$8,336$1,066.78+$28.9KSHANF
4$44,152$4,292.27$8,437$1,384.80+$35.7KSHANF
5$49,862$2,619.72$9,013$1,875.40+$40.8KSHANF
6$54,876$1,523.51$10,306$2,680.72+$44.6KSHANF
7$59,580$863.43$12,820$4,101.38+$46.8KSHANF
8$64,234$482.74$17,673$6,826.70+$46.6KSHANF
9$68,998$268.01$27,543$12,591.86+$41.5KSHANF
10$73,976$148.25$49,560$26,258.71+$24.4KSHANF

SHANF vs PFE: Complete Analysis 2026

SHANFStock

Shandong Molong Petroleum Machinery Company Limited engages in the design, research and development, production, and sale of products for the energy equipment industry in the People's Republic of China. The company operates through Pipe Products, Three Kinds of Pumping Units, Petroleum Machinery Parts, Tube Blank, High-End Castings and Forgings, and Others segments. The company's products include API and non API casing products, line pipe products, precision steel pipes, hydraulic prop tubes, fluid pipes, cylinder tubes, and boiler tubes; sucker rods; and valve body, cylinder liners, gate valves, and billet products. Its products are used in petroleum, natural gas, coalbed methane, shale gas, machinery processing, urban pipe network, etc., as well as used in equipment for oil and gas drilling, and wind turbine castings. In addition, the company engages in the research of new materials for energy equipment; production and sale of metal casting and forging; sea water desalination activities; waste heat and gas power generation activities; and manufacture and sale of special equipment. It also exports its energy equipment. Shandong Molong Petroleum Machinery Company Limited was founded in 2001 and is based in Shouguang City, China.

Full SHANF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this SHANF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHANF vs SCHDSHANF vs JEPISHANF vs OSHANF vs KOSHANF vs MAINSHANF vs JNJSHANF vs MRKSHANF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.